NL8202379A - Menselijke t-cellijnen en werkwijze voor het bereiden van deze cellijnen. - Google Patents

Menselijke t-cellijnen en werkwijze voor het bereiden van deze cellijnen. Download PDF

Info

Publication number
NL8202379A
NL8202379A NL8202379A NL8202379A NL8202379A NL 8202379 A NL8202379 A NL 8202379A NL 8202379 A NL8202379 A NL 8202379A NL 8202379 A NL8202379 A NL 8202379A NL 8202379 A NL8202379 A NL 8202379A
Authority
NL
Netherlands
Prior art keywords
cells
cell line
human
hybrid
cell
Prior art date
Application number
NL8202379A
Other languages
English (en)
Dutch (nl)
Original Assignee
Yamamura Yuichi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP56091265A external-priority patent/JPS57206383A/ja
Priority claimed from JP56122815A external-priority patent/JPS5823785A/ja
Application filed by Yamamura Yuichi filed Critical Yamamura Yuichi
Publication of NL8202379A publication Critical patent/NL8202379A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
NL8202379A 1981-06-12 1982-06-11 Menselijke t-cellijnen en werkwijze voor het bereiden van deze cellijnen. NL8202379A (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP56091265A JPS57206383A (en) 1981-06-12 1981-06-12 Human t cellular line
JP9126581 1981-06-12
JP12281581 1981-08-04
JP56122815A JPS5823785A (ja) 1981-08-04 1981-08-04 ヒトｔ細胞ライン

Publications (1)

Publication Number Publication Date
NL8202379A true NL8202379A (nl) 1983-01-03

Family

ID=26432716

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8202379A NL8202379A (nl) 1981-06-12 1982-06-11 Menselijke t-cellijnen en werkwijze voor het bereiden van deze cellijnen.

Country Status (16)

Country Link
US (1) US4544632A (no)
AT (2) AT387235B (no)
AU (1) AU555913B2 (no)
CA (1) CA1189805A (no)
CH (1) CH663795A5 (no)
DE (2) DE3249567C2 (no)
DK (1) DK255882A (no)
ES (1) ES513027A0 (no)
FI (1) FI76118C (no)
FR (1) FR2507620A1 (no)
GB (1) GB2102832B (no)
IT (1) IT1164454B (no)
NL (1) NL8202379A (no)
NO (1) NO162669C (no)
NZ (1) NZ200849A (no)
SE (2) SE8203623L (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0096839B1 (en) * 1982-06-09 1989-01-25 Asahi Kasei Kogyo Kabushiki Kaisha Method for producing human antibody
NZ206699A (en) * 1982-12-30 1989-08-29 Bio Response Inc Process for the production of serum independent cell lines
JPS59169492A (ja) * 1983-03-15 1984-09-25 Asahi Chem Ind Co Ltd ヒト融合細胞からの生理活性物質の産生方法
JPS59169489A (ja) * 1983-03-15 1984-09-25 Otsuka Pharmaceut Co Ltd ヒト培養株化細胞
US4728614A (en) * 1983-05-18 1988-03-01 Ortho Pharmaceutical Mutant human T cell line producing immunosuppressive factor and method for obtaining such mutants
US4843004A (en) * 1984-05-11 1989-06-27 Sloan-Kettering Institute For Cancer Research Method for the production of human T-T cell hybrids and production suppressor factor by human T-T cell hybrids
US4665032A (en) * 1984-06-28 1987-05-12 Cornell Research Foundation, Inc. Human T cell hybridomas which produce immunosuppressive factors
ATE82588T1 (de) * 1986-04-28 1992-12-15 Endotronics Inc Zuchtverfahren fuer leukocyten.
NO162160C (no) * 1987-01-09 1989-11-15 Medi Cult As Serumfritt vekstmedium, samt anvendelse derav.
US5112735A (en) * 1987-06-22 1992-05-12 University Of Vermont Detection of lymphocyte amplification
US5482837A (en) * 1994-01-14 1996-01-09 University Of Vermont Methods of identifying lymphocytes with mutator phenotypes
US6113903A (en) * 1989-03-21 2000-09-05 The Immune Response Corporation Peptides and methods against diabetes
US5827642A (en) * 1994-08-31 1998-10-27 Fred Hutchinson Cancer Research Center Rapid expansion method ("REM") for in vitro propagation of T lymphocytes
US6316257B1 (en) 1996-03-04 2001-11-13 Targeted Genetics Corporation Modified rapid expansion methods (“modified-REM”) for in vitro propagation of T lymphocytes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT292366B (de) * 1968-08-28 1971-08-25 Johann Sackl Schweinezuchtstall
WO1982001461A1 (en) * 1980-07-18 1982-05-13 Leland Stanford Junior Univ Human hybridomas,precursors and products
US4451570A (en) * 1981-03-26 1984-05-29 The Regents Of The University Of California Immunoglobulin-secreting human hybridomas from a cultured human lymphoblastoid cell line
US4401756A (en) * 1981-04-14 1983-08-30 Immunex Corporation Process for preparing human interleukin 2
US4407945A (en) * 1981-04-29 1983-10-04 Immunex Corporation Constitutive production of interleukin 2 by a T cell hybridoma
US4434230A (en) * 1981-08-12 1984-02-28 Research Corporation Human nonsecretory plasmacytoid cell line

Also Published As

Publication number Publication date
DE3222072C2 (de) 1986-08-14
FR2507620B1 (no) 1984-10-19
SE460852B (sv) 1989-11-27
NO821949L (no) 1982-12-13
SE8203623L (sv) 1982-12-13
US4544632A (en) 1985-10-01
ES8305039A1 (es) 1983-04-01
DE3222072A1 (de) 1983-04-07
IT8205179A0 (it) 1982-06-10
GB2102832B (en) 1985-03-20
ES513027A0 (es) 1983-04-01
ATA281883A (de) 1984-08-15
AT387235B (de) 1988-12-27
FI76118C (fi) 1988-09-09
CH663795A5 (de) 1988-01-15
ATA230482A (de) 1988-05-15
NO162669B (no) 1989-10-23
AU8447482A (en) 1982-12-16
FI822103A0 (fi) 1982-06-11
DK255882A (da) 1982-12-13
FR2507620A1 (fr) 1982-12-17
NO162669C (no) 1990-01-31
NZ200849A (en) 1985-01-31
AT377415B (de) 1985-03-25
IT1164454B (it) 1987-04-08
CA1189805A (en) 1985-07-02
AU555913B2 (en) 1986-10-16
GB2102832A (en) 1983-02-09
DE3249567C2 (de) 1986-10-02
FI76118B (fi) 1988-05-31

Similar Documents

Publication Publication Date Title
Lake et al. Production and characterization of cytotoxic Thy‐1 antibody‐secreting hybrid cell lines Detection of T cell subsets
Bramwell et al. An abnormal membrane glycoprotein associated with malignancy in a wide range of different tumours
Chamley et al. Comparison of vascular smooth muscle cells from adult human, monkey and rabbit in primary culture and in subculture
DE60132475T2 (de) Neue tumorassoziierte marker
Armstrong et al. Affected paroxysmal nocturnal hemoglobinuria T lymphocytes harbor a common defect in assembly of N-acetyl-D-glucosamine inositol phospholipid corresponding to that in class A Thy-1-murine lymphoma mutants.
JP2648419B2 (ja) モノクローナル抗体混合物
Coleman et al. A clonal study of the reversible inhibition of muscle differentiation by the halogenated thymidine analog 5-bromodeoxyuridine
NL8202379A (nl) Menselijke t-cellijnen en werkwijze voor het bereiden van deze cellijnen.
Pauly et al. Immunofluorescent patterns of spectrin in lymphocyte cell lines.
Hunt et al. Isolation of phenotypically distinct trophoblast cell lines from normal rat chorioallantoic placentas
Deugnier et al. Characterization of rat T cell precursors sorted by chemotactic migration toward thymotaxin
Kuliev et al. Morphological, autoradiographic, immunochemical and cytochemical investigation of a cell strain with trisomy 7 from a spontaneous abortus
US4970162A (en) Human-mouse hybrid cell line expressing monocyte-macrophage properties
Keller et al. Interleukins 2 and 3 regulate the in vitro proliferation of two distinguishable populations of 20-alpha-hydroxysteroid dehydrogenase-positive cells.
JP2752351B2 (ja) リンパ球の同定方法
Mikami et al. Carboxyl-terminal deletion and point mutations decrease the transforming potential of the activated rat neu oncogene product.
JP4250017B2 (ja) 核を持たずにミトコンドリア活性を示す培養可能なミトコンドリア細胞
Klebe Genetic mapping of a human regulator gene
Ralph Continuous cell lines with properties of mononuclear phagocytes
JP4849408B2 (ja) タンパク質産生新規ヒト細胞株、新規ヒト細胞株の選択方法、新規ヒト細胞株の使用、それらからのタンパク質産生方法及び精製方法、及び新規ヒト細胞株を利用した薬学組成物
Brooks Cloning and culturing of fetal mouse natural killer cells
NO162915B (no) Fremgangsmaate for fremstilling av en human-t-hybrid-cellelinje.
Kosower et al. Membrane mobility agents: V. Genetic variability in the fusibility of hen red cells
Tsuchiya et al. Epstein-Barr virus-induced precursor B cell lines from patients with congenital agammaglobulinemia
US4849507A (en) Human suppressor factor